Q. for SH meeting. If the results of the shorter test are positive what does that possibly do to the timeline for approval of GR-MD-02? Will the psoriasis trial allow for a quicker approval of GR-MD-02? What do you anticipate will be the first indication to bring GR-MD-02 FDA approval and get it on the market?